CryoPort, Minaris Partner to Support Advancement of Cell and Gene Therapies

Will provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies.

Author Image

By: Charlie Sternberg

Associate Editor

CryoPort Inc., a provider of supply chain solutions for the life sciences, and Minaris Regenerative Medicine, LLC, a global contract development and manufacturing organization for cell and gene therapies, have partnered to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.   The collaboration combines Cryoport’s capabilities and experience in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters